Clinical Research Directory
Browse clinical research sites, groups, and studies.
BostonGene and Exigent Genomic INsight Study
Sponsor: BostonGene
Summary
The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.
Official title: BostonGene and Exigent Genomic INsight (BEGIN) Study: A Prospective Study of Comprehensive Molecular Testing in Advanced Cancer Patients in the Community Setting
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2024-04-08
Completion Date
2028-01-08
Last Updated
2025-02-17
Healthy Volunteers
No
Locations (7)
Highlands Oncology Group
Rogers, Arkansas, United States
Stockton Hematology Oncology Medical Group
Stockton, California, United States
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
New Mexico Cancer Center
Albuquerque, New Mexico, United States
Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma, United States
Oncology Consultants
Houston, Texas, United States
Northwest Medical Specialities
Puyallup, Washington, United States